Related Experiment Video
Updated: Apr 5, 2026

3D Culturing of Organoids from the Intestinal Villi Epithelium Undergoing Dedifferentiation
Published on: April 1, 2021
Achaete scute-like 2 suppresses CDX2 expression and inhibits intestinal neoplastic epithelial cell differentiation
Yangyang Shang1, Qiong Pan1, Lei Chen1
1Department of Gastroenterology, Southwest Hospital, Third Military Medical University, Chongqing, P. R. China.
Abstract:
The role of Achaete scute-like 2 (Ascl2) in colorectal cancer (CRC) cell differentiation is unknown. LS174T, HT-29 and Caco-2 cells have high Ascl2 expression, while Lovo and SW480 cells have low Ascl2 expression. LS174T and HT-29 cells with Ascl2 knockdown were transfected with caudal type homeobox 2 (CDX2) promoter constructs and used for luciferase assays and chromatin immunoprecipitation (ChIP) assays. Ascl2 knockdown promoted differentiation of CRC cells into a goblet cell phenotype, as determined by increased expression of MUC2, TFF3, and CDX2. Ascl2 knockdown activated CDX2 expression through a transcriptional mechanism via direct binding of Ascl2 to the proximal E-box of the CDX2 promoter. Ascl2 over-expression in Lovo and SW480 cells inhibited a goblet cell phenotype, as determined by reduced CDX2 and MUC2 expression. Inverse correlations between Ascl2 and CDX2, and Ascl2 and MUC2 mRNA levels, as well as Ascl2 and CDX2 protein levels were observed in CRC cancerous samples. This study demonstrates CDX2 repression by Ascl2 and highlights a role for Ascl2 in CRC cell differentiation. These findings suggest that the Ascl2/CDX2 axis may serve as a potential therapeutic target in colorectal cancer.
Insights
Achaete scute-like 2 (Ascl2) represses colorectal cancer (CRC) cell differentiation by inhibiting caudal type homeobox 2 (CDX2) expression. Targeting the Ascl2/CDX2 pathway may offer new CRC therapies.
Area of Science:
- Molecular biology
- Cancer research
- Cell differentiation
Background:
- The role of Achaete scute-like 2 (Ascl2) in colorectal cancer (CRC) cell differentiation remains unclear.
- Ascl2 expression varies across different CRC cell lines, suggesting a potential role in cancer progression.
Purpose of the Study:
- To investigate the function of Ascl2 in CRC cell differentiation.
- To elucidate the regulatory relationship between Ascl2 and caudal type homeobox 2 (CDX2).
Main Methods:
- Utilized Ascl2 knockdown and over-expression in CRC cell lines (LS174T, HT-29, Lovo, SW480).
- Performed luciferase assays and chromatin immunoprecipitation (ChIP) to assess transcriptional regulation.
- Analyzed MUC2, TFF3, and CDX2 expression at mRNA and protein levels.
- Correlated Ascl2, CDX2, and MUC2 levels in CRC patient samples.
Main Results:
- Ascl2 knockdown promoted CRC cell differentiation into goblet cells, indicated by increased MUC2, TFF3, and CDX2.
- Ascl2 directly binds to the CDX2 promoter, transcriptionally activating its expression.
- Ascl2 over-expression inhibited goblet cell differentiation markers (CDX2, MUC2).
- Inverse correlations observed between Ascl2 and CDX2/MUC2 in CRC tissues.
Conclusions:
- Ascl2 acts as a repressor of CDX2 expression in CRC.
- Ascl2 plays a significant role in regulating CRC cell differentiation.
- The Ascl2/CDX2 axis represents a potential therapeutic target for colorectal cancer treatment.
Related Concept Videos
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Renewal of Intestinal Stem Cells
Hedgehog Signaling Pathway

